Eugin Group
PE-backed
Co-acquirer (with IVI RMA) of Eugin Group from Fresenius Helios in 2023. Eugin owns Boston IVF in the US. Significant for the Boston IVF ownership-chain case study: NMC Health (2019) -> Fresenius Helios (2021) -> IVI RMA + GED Capital (2023). Boston IVF patients have had four corporate parents in five years.